The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Official Title: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Study ID: NCT03663725
Brief Summary: Due to conflicting data on the optimal moment to start TMZ chemotherapy and the impact of prolongation of the adjuvant phase with TMZ, the ANOCEF (Association des Neuro-Oncologues d'Expression Francophone) group proposes this randomized trial comparing an intensified arm (early TMZ and extended adjuvant TMZ until toxicity, progression or patient refusal) versus the classical EORTC regimen as control (RT and concomitant TMZ started 4-6 weeks after surgery followed by a number of adjuvant TMZ cycles strictly limited to 6) for primary GBM adult patients.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre Hospitalier d'Amiens, Amiens, , France
ICO Centre Paul Papin, Angers, , France
Centre François Baclesse, Caen, , France
Centre Jean Perrin, Clermont-Ferrand, , France
Hôpitaux Civils de Colmar, Colmar, , France
Centre Georges François Leclerc, Dijon, , France
CHU Grenoble Alpes, Grenoble, , France
CHU de Limoges, Limoges, , France
Centre Léon Bérard, Lyon, , France
CHU La Timone, Marseille, , France
ICM Val d'Aurelle, Montpellier, , France
CHRU Nancy, Nancy, , France
ICO Centre René Gauducheau, Nantes, , France
CHU de Nice - Hôpital de Cimiez, Nice, , France
APHP La Pitié Salpêtrière, Paris, , France
CH René Dubos, Pontoise, , France
Institut Cancérologie Loire, Saint-Priest-en-Jarez, , France
Centre Paul Strauss, Strasbourg, , France
CHRU Tours, Tours, , France
Name: Florence LEFRANC, MD
Affiliation: ERASME
Role: PRINCIPAL_INVESTIGATOR
Name: Bruno CHAUFFERT, MD
Affiliation: CHU Amiens
Role: PRINCIPAL_INVESTIGATOR